We are live on
!
Find out more
Eli Lilly
2,300 hedge funds and large institutions have $217B invested in Eli Lilly in 2021 Q4 according to their latest regulatory filings, with 371 funds opening new positions, 852 increasing their positions, 685 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 2,047 → 2,300 (+253)
0.29% less ownership
Funds ownership: 82.82% → 82.53% (-0.29%)
25% less call options, than puts
Call options by funds: $1.77B | Put options by funds: $2.37B
Holders
2,300
Holding in Top 10
79
Calls
$1.77B
Puts
$2.37B
Top Buyers
| 1 | +$932M | |
| 2 | +$590M | |
| 3 | +$333M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$319M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$275M |
Top Sellers
| 1 | -$1.29B | |
| 2 | -$763M | |
| 3 | -$286M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$278M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$238M |